Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Cirugía y cirujanos
versión On-line ISSN 2444-054Xversión impresa ISSN 0009-7411
Resumen
RUIZ-PARDO, José et al. Results of treatment of papillary thyroid microcarcinoma adapted to risk of recurrence. Cir. cir. [online]. 2020, vol.88, n.5, pp.576-583. Epub 08-Nov-2021. ISSN 2444-054X. https://doi.org/10.24875/ciru.20001560.
Background:
The incidence of papillary thyroid microcarcinoma (PTMC) is increasing.
Objective:
To analyze the long-term prognosis of PTMC.
Method:
Study population: patients with a histopathological diagnosis of PTMC (size ≤ 1 cm) treated according to the risk of recurrence of the Latin American Thyroid Society. Inclusion criteria: minimum follow-up of 2 years, availability of histopathological samples, and treatment compliance. Exclusion criteria: previous thyroid surgery, other synchronous malignancies or ectopic location of the PTMC. Study variables: persistences, recurrences and mortality.
Results:
Based on the risk of recurrence, PTMC has very low risk in 65.2% (n = 105), low risk in 17.4% (n = 28) and high risk in 17.4% (n = 28). In high risk patients, total thyroidectomy was performed in all cases, cervical lymphadenectomy in 57,1% (n = 16) and metabolic therapy with I131 in all cases. During a mean follow-up of 119,8 ± 65 months, 0.6% (n = 1) of recurrences took place. Risk factors associated to recurrence were not identified. No patient died due to MCPT.
Conclusions:
PTMC treated based on its risk of recurrence has a good long-term prognosis, without persistences, with a low number of recurrences and absence of disease-associated mortality.
Palabras llave : Thyroid cancer; Papillary thyroid carcinoma; Papillary thyroid microcarcinoma; Prognosis; Treatment.